Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cardamom pods (Elettaria cardamomum) contain bioactive essential oils—primarily 1,8-cineole (20–50%) and α-terpinyl acetate (25–45%)—along with flavonoids such as quercetin and kaempferol, which collectively modulate NF-κB, PI3K/Akt, and MAPK inflammatory signaling pathways to deliver potent antioxidant, anti-inflammatory, and cardiometabolic effects. These compounds demonstrate significant DPPH free-radical scavenging activity, support digestive enzyme secretion, and have shown blood-pressure-lowering potential in preliminary human trials, making cardamom one of the most pharmacologically versatile culinary spices.
Reported Benefits (Provisional)
Origin & History
Cardamom (Elettaria cardamomum) is an aromatic spice derived from the seeds of a plant in the ginger family. It is native to the forests of India, Sri Lanka, and other parts of Southeast Asia, now widely cultivated in tropical and subtropical regions. Revered for its potent volatile oils and antioxidants, cardamom offers significant benefits for digestive and respiratory health.
Research Narrative (Provisional)
Research on cardamom has demonstrated a range of therapeutic effects, though large-scale randomized clinical trials remain limited. A double-blind, placebo-controlled trial published in the Indian Journal of Biochemistry and Biophysics (2009) found that 3 g/day of cardamom powder for 12 weeks significantly reduced systolic and diastolic blood pressure in stage-1 hypertensive subjects (n=20) while enhancing total antioxidant status and fibrinolytic activity. In vitro and animal studies published in journals including the Journal of Ethnopharmacology and Phytomedicine have demonstrated cardamom's gastroprotective effects, antimicrobial activity against oral pathogens such as Streptococcus mutans, and anti-inflammatory activity via inhibition of COX-2 and iNOS expression. Additional research in the International Journal of Molecular Sciences has explored cardamom's chemopreventive potential through modulation of phase II detoxification enzymes and suppression of NF-κB-driven cytokine release, though human confirmation studies are still ongoing.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Volatile oils: Cineole (eucalyptol), limonene, myrcene, terpinene - Flavonoids and polyphenols (antioxidants, anti-inflammatory compounds) - Vitamins: B vitamins, Vitamin C - Minerals: Potassium, magnesium, calcium
Reported Mechanism (Provisional)
The primary bioactive compound 1,8-cineole (eucalyptol) inhibits the NF-κB signaling cascade by preventing IκBα phosphorylation and nuclear translocation of p65, thereby suppressing pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, while also inhibiting cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression. α-Terpinyl acetate and limonene contribute additional antioxidant capacity through direct free-radical scavenging and upregulation of endogenous antioxidant enzymes—superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)—via activation of the Nrf2/ARE transcriptional pathway. The flavonoids quercetin and kaempferol modulate PI3K/Akt/mTOR and MAPK/ERK signaling, inhibiting excessive cell proliferation and promoting apoptosis in aberrant cells, while also chelating transition metal ions to prevent Fenton-reaction-mediated lipid peroxidation. Collectively, these compounds exert a multi-target pharmacological profile that includes vasodilation through calcium-channel antagonism and cholinergic stimulation of digestive enzyme secretion.
Clinical Narrative (Provisional)
Clinical evidence remains limited with most data derived from in vitro and animal studies rather than large-scale human trials. Laboratory studies demonstrate IC50 values of 67.98 µg/mL against HT-29 colorectal cancer cells and DPPH scavenging EC50 of 206.6 μg/mL. In rat studies using 1% cardamom powder, significant improvements in catalase/SOD activity and glutathione restoration were observed compared to controls (p<0.05). Human clinical trials are needed to validate therapeutic efficacy and establish standardized dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.